Aspire Biopharma Holdings Inc is a PR-based company operating in Pharmaceuticals industry. Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.
ASBP stock price ended at $1.46 on 金曜日, after rising 10.61%
On the latest trading day Feb 06, 2026, the stock price of ASBP rose by 10.61%, climbing from $1.35 to $1.46. Throughout the session, the stock experienced a volatility of 18.25%, with prices fluctuating between a daily low of $1.26 and a high of $1.49. Alongside this price increase, trading volume also rose by 198.4K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 205.4K shares were traded, amounting to a market value of approximately $156.9M.